vktx stock forecast zacks

Their forecasts range from 1000 to 2100. The companys lead compounds include.

Intercept Icpt Outperforms Industry In 3 Months What Lies Ahead Nasdaq

Youll find the Viking Therapeutics share forecasts stock quote and buy sell signals belowAccording to present data Viking Therapeuticss VKTX shares and potentially its market environment have been in bearish.

. The consensus price target hints at a 2041 upside potential for Viking Therapeutics Inc. Zacks Investment Research is releasing its prediction for VKTX based on the 1-3 month trading system that nearly triples the SP 500. Wall Street Stock Market Finance report prediction for the future.

Viking Therapeutics Inc 237 005 207 Watch. NASDAQVKTX Get Rating will announce 021 earnings per share EPS for. A B is better than a C.

5 months ago -. Stock news by MarketWatch. Several equities research analysts have weighed in on the stock.

8990 of the stock is. The Viking Therapeutics stock price gained 250 on the last trading day Monday 25th Apr 2022 rising from 240 to 246. Rooms Shows Rankings Earnings Newsletters Shop.

During the day the stock fluctuated 380 from a day low at 237 to a day high of 246. Viking Therapeutics has a one year low of 215 and a one year high of. Zacks Investment Research is releasing its prediction for VKTX based on the 1-3 month trading system that nearly triples the SP 500.

Find real-time VKTX - Viking Therapeutics Inc stock quotes company profile news and forecasts from CNN Business. Viking Therapeutics has a 12 month low of 215 and a 12 month high of. And a D is better than an F.

NASDAQVKTX announced that results from the Phase 2 clinical trial of VK5211 in patients with hip fracture were presented at the 2018 American Society for Bone and Mineral Research ASBMR Annual Meeting. The firm has a market cap of 18415 million a PE ratio of -322 and a beta of 167. 7 hours agoWall Street analysts forecast that OraSure Technologies Inc.

VKTX announced the closing of a previously announced public offering of 75 million shares of its common stock and warrants to purchase up to 75 million shares of common stock at a public offering price of 125 per share. Buy or sell Viking Therapeutics stock. The warrants have an exercise price of 150 and are exercisable until Apr.

VKTX Complete Viking Therapeutics Inc. Viking Therapeutics Inc Stock Market info Recommendations. The price has fallen in 6 of the last 10 days and is down by -1517 for this period.

Enrollment of Phase 2 Trial of VK2809 Nearing Completion. Finance Forbes and others. 13 hours agoShares of VKTX stock opened at 238 on Monday.

1 VK5211 which is being developed for acute rehabilitation following non-elective hip fracture surgery. While empirical research shows that this sought-after metric is hardly effective an upward trend in e. On average they anticipate Viking Therapeutics stock price to reach 1550 in the next year.

2022 at 915 am. Viking Therapeutics has a 12 month low of 215 and a 12 month high of 720. This suggests a possible upside of 4657 from the stocks current price.

12 hours agoZacks Investment Research cut Viking Therapeutics from a buy rating to a hold rating in a report on Friday January 7th. NASDAQVKTX Get Rating to post earnings per share of 021 for the current quarter according to Zacks Investment Research. On October 1 2018 Viking Therapeutics Inc.

This was a multicenter randomized double blind placebo controlled trial that enrolled a. Its used by Nasdaq Yahoo. As an investor you want to.

Wall Street Analysts Think 204. Check out Zacks stock rank on your favorite tickers today absolutely FREE. View real-time stock prices and stock quotes for a full financial overview.

Ad Experts trust Zacks research. 12 hours agoNASDAQ VKTX opened at 238 on Monday. NASDAQVKTX is a biopharmaceutical company developing treatments for metabolic and endocrine disorders.

On April 13 2016 Viking Therapeutics Inc. 7 hours agoWall Street brokerages expect Viking Therapeutics Inc. Equities analysts forecast that Viking Therapeutics Inc.

A C is better than a D. NASDAQOSUR Get Rating will announce 014 earnings per share for the current fiscal quarter Zacks reports. Volume fell on the last day by -330 thousand.

Barclays cut their target price on shares of Allegiant Travel from 27500 to. Click here - the VKTX analysis is free About Price and. Two Sigma Investments LP now owns 82215 shares of the restaurant operators stock valued at 149427000 after acquiring an additional 83215 shares during the period.

View analysts price targets for Viking Therapeutics or view top-rated stocks among Wall Street analysts. Real-time trade and investing ideas on Viking Therapeutics Inc VKTX from the largest community of traders and investors. An A is better than a B.

Zacks Analysts Expect Blackstone Inc Nyse Bx Will Post Quarterly Sales Of 3 39 Billion Defense World